PA: Xylazine (tranq) exposure among people who use substances in Philadelphia

First detected in Philadelphia in 2006, xylazine has been associated with increasing fatal overdoses and chronic wounds. From 2015 to 2021, the number of fatal overdoses involving xylazine per year increased from 15 to 434.2 Point of care testing for xylazine is not yet available, so people who use substances may not be aware that they have been exposed to xylazine.

Loader Loading...
EAD Logo Taking too long?
Reload Reload document
| Open Open in new tab

Download

Copyright © 2025 - NADDI. All Rights Reserved.

Disclaimer / Privacy Policy / Copyright Policy

Log in with your credentials

Forgot your details?